"Revolutionary Antibiotic Emerges as Hope Against Drug-Resistant Superbugs"
TL;DR
Researchers have discovered a new antibiotic, zosurabalpin, that shows promise in fighting the drug-resistant superbug Acinetobacter baumannii (CRAB). This new compound disrupts the transport of a key bacterial toxin to the outer membrane, a novel approach not seen in other FDA-approved antibiotics. While the drug has been effective in mouse studies and is currently in Phase I human trials, scientists caution that bacteria may eventually develop resistance to this new antibiotic as well. The development of zosurabalpin represents a significant breakthrough in the ongoing battle against multidrug-resistant bacteria.
Topics:healthhealth-and-medicine#acinetobacter-baumannii#antibiotic-resistance#drug-development#health-and-medicine#superbugs#zosurabalpin
- New type of antibiotic targets drug-resistant bugs, study says Los Angeles Times
- A novel antibiotic class targeting the lipopolysaccharide transporter Nature.com
- New antibiotic uses novel method to target deadly drug-resistant bacteria, study says CNN
- Scientists hail new antibiotic that can kill drug-resistant bacteria The Guardian
- New drug offers hope in fight against hospital 'superbugs' Financial Times
Want the full story? Read the original reporting
Read on Los Angeles Times